Name | Butoconazole nitrate |
Synonyms | exelgyn Butoconazole nitrate (+-)-1-(4-(p-Chlorophenyl)-2-( 1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]imidazole 1-(4-(4-Chlorophenyl)-2-(2,6-dichlorophenylthio)-n-butyl)imidazole nitrate (+-)-1-(4-(4-chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-1h-imidazolem 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanyl-butyl]imidazole nitrate 1-[4-(4-Chlorophenyl)-2-(2,6-dichlorophenyl)sulfanyl-butyl]imidazole nitrate 1-(4-(4-chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-1h-imidazol(+-)-1h-imidazol Butoconazole nitrate 1-[4-(4-Chlorophenyl)-2-(2,6-dichlorophenyl)sulfanyl-butyl]imidazole nitrate |
CAS | 64872-77-1 |
EINECS | 613-721-6 |
InChI | InChI=1/C19H17Cl3N2S.HNO3/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22;2-1(3)4/h1-5,7-8,10-11,13,16H,6,9,12H2;(H,2,3,4) |
InChIKey | ZHPWRQIPPNZNML-UHFFFAOYSA-N |
Molecular Formula | C19H18Cl3N3O3S |
Molar Mass | 474.79 |
Melting Point | 159°C (dec.) |
Boling Point | 566.9°C at 760 mmHg |
Flash Point | 296.7°C |
Solubility | DMSO or DMF: soluble |
Vapor Presure | 2.76E-12mmHg at 25°C |
Appearance | powder |
Color | White to Off-White |
Merck | 14,1529 |
Storage Condition | Sealed in dry,2-8°C |
In vitro study | Imidazoles generally inhibit the conversion of lanosterol to ergosterol, resulting in a change in fungal cell membrane lipid composition. This structural change alters cell permeability and, ultimately, results in the osmotic disruption or growth inhibition of the fungal cell. |
Hazard Symbols | Xn - Harmful |
Risk Codes | 22 - Harmful if swallowed |
WGK Germany | 3 |
RTECS | NI4399500 |
HS Code | 2933290000 |
Toxicity | LD50 in mice, male, female rats (mg/kg): >3200, >3200, 1720 orally; >1600, 940, 940 i.p. (Walker) |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.106 ml | 10.531 ml | 21.062 ml |
5 mM | 0.421 ml | 2.106 ml | 4.212 ml |
10 mM | 0.211 ml | 1.053 ml | 2.106 ml |
5 mM | 0.042 ml | 0.211 ml | 0.421 ml |